Healthcare / Health Information ServicesTokyo
$1059.00
-38.00 (-3.46%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $553.2M · quality 66.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
61/100
B
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$13.2B
P/E
15.7x
↓EV/EBITDA
6.4x
↓ROE
22.5%
↑Gross Margin
20.0%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2025 · 2 años de histórico normalizado
Revenue CAGR
+14.4%
FCF CAGR
+60.0%
FCF margin
10.1%
FCF / Net income
1.82x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.06B · net income $776.2M · FCF $1.42B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $14.06B | $14.06B | $13.27B | $10.75B |
| Net Income | $776.2M | $776.2M | $680.4M | $560.3M |
| EBITDA | $1.36B | $1.36B | $1.18B | $1.02B |
| EPS | 71.23 | 71.23 | 62.44 | 46.70 |
| Gross Margin | 20.0% | 20.0% | 19.4% | 20.9% |
| Operating Margin | 7.9% | 7.9% | 7.3% | 7.7% |
| Net Margin | 5.5% | 5.5% | 5.1% | 5.2% |
| Balance Sheet | ||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.25 | 2.25 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $1.42B | $1.42B | $129.7M | $553.2M |
| Returns | ||||
| ROE | 22.5% | 22.5% | 23.6% | 23.7% |
| Valuation | ||||
| P/E | 15.72 | 15.72 | — | — |
| EV/EBITDA | 6.44 | 6.44 | — | — |
| P/B | 3.34 | 3.34 | — | — |
| Growth & Yield | ||||
| Revenue Growth | 6.0% | 6.0% | 23.4% | — |
| EPS Growth | 14.1% | 14.1% | 33.7% | — |
| Dividend Yield | 7.6% | 7.6% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
9.7%
EPS terminal req.
$93.97
Spread vs growth
4.4%
5Y implied EPS CAGR
9.8%
EPS terminal req.
$113.70
Spread vs growth
4.3%
10Y implied EPS CAGR
9.9%
EPS terminal req.
$183.12
Spread vs growth
4.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-34.6%
Start / end P/E
29.3x → 14.9x
EPS bridge
62.44 → 71.23
Residual
-6.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.